A detailed history of Ashton Thomas Securities, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Ashton Thomas Securities, LLC holds 127 shares of CTLT stock, worth $7,453. This represents 0.0% of its overall portfolio holdings.

Number of Shares
127
Holding current value
$7,453
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$56.16 - $60.96 $7,132 - $7,741
127 New
127 $7.69 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Ashton Thomas Securities, LLC Portfolio

Follow Ashton Thomas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Securities, LLC with notifications on news.